RA
Robert Andrade
Chief Financial Officer

Robert Andrade insider trades: Fennec Pharmaceuticals (FENC) stock sales

Chief Financial Officer, Fennec Pharmaceuticals Last trade Aug 27, 2026 57 Form 4 filings
$884K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
6
Open-market trades
since 2022
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Robert reports to the SEC

Open-market buys and sales

6 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 27, 2026FENC↓ Sell$884K
Mar 26, 2024FENC↓ Sell$152K
Mar 25, 2024FENC↓ Sell10b5-1$154K
Jan 5, 2024FENC↓ Sell$316K
Jun 30, 2023FENC↓ Sell$223K
Dec 30, 2022FENC↓ Sell$211K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other FENC insiders

Open-market trades in the last 12 months

About Robert Andrade's insider trades

Robert Andrade is Chief Financial Officer at Fennec Pharmaceuticals (FENC). Since Dec 30, 2022, Robert has reported no open-market purchases and 6 sales worth $1.9M on SEC Form 4. In the last 12 months: 1 sale ($884K).

1 sale (8% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.

Their filings also include grants and awards (41 filings), option exercises (12 filings), shares returned to the company (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FENC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.